Cargando…
Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850223/ https://www.ncbi.nlm.nih.gov/pubmed/36687420 http://dx.doi.org/10.3389/fmed.2022.1125836 |
| _version_ | 1784872136577384448 |
|---|---|
| author | Hou, Zhanying Su, Xuehan Han, Guangming Xue, Ruzeng Chen, Yangxia Chen, Ye Wang, Huan Yang, Bin Liang, Yunsheng Ji, Suyun |
| author_facet | Hou, Zhanying Su, Xuehan Han, Guangming Xue, Ruzeng Chen, Yangxia Chen, Ye Wang, Huan Yang, Bin Liang, Yunsheng Ji, Suyun |
| author_sort | Hou, Zhanying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9850223 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98502232023-01-20 Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis Hou, Zhanying Su, Xuehan Han, Guangming Xue, Ruzeng Chen, Yangxia Chen, Ye Wang, Huan Yang, Bin Liang, Yunsheng Ji, Suyun Front Med (Lausanne) Medicine Frontiers Media S.A. 2023-01-05 /pmc/articles/PMC9850223/ /pubmed/36687420 http://dx.doi.org/10.3389/fmed.2022.1125836 Text en Copyright © 2023 Hou, Su, Han, Xue, Chen, Chen, Wang, Yang, Liang and Ji. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Hou, Zhanying Su, Xuehan Han, Guangming Xue, Ruzeng Chen, Yangxia Chen, Ye Wang, Huan Yang, Bin Liang, Yunsheng Ji, Suyun Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis |
| title | Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis |
| title_full | Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis |
| title_fullStr | Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis |
| title_full_unstemmed | Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis |
| title_short | Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis |
| title_sort | corrigendum: jak1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850223/ https://www.ncbi.nlm.nih.gov/pubmed/36687420 http://dx.doi.org/10.3389/fmed.2022.1125836 |
| work_keys_str_mv | AT houzhanying corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT suxuehan corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT hanguangming corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT xueruzeng corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT chenyangxia corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT chenye corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT wanghuan corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT yangbin corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT liangyunsheng corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis AT jisuyun corrigendumjak12inhibitorbaricitinibimprovesskinfibrosisanddigitalulcersinsystemicsclerosis |